Effect of Breather in COPD Patients With Intermittent Claudication

ConditionsCOPDPAD
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexMale
Age50-60
SponsorCairo University

About this trial

The aim of this study To show the effect of breather on ventilatory and vascular function in COPD patient with intermittent claudication.

Eligibility criteria

Qualifiers

sixty male patients with diagnosed with grade I and grade II COPD their ages ranged between 55-60years

All patients will be clinically and medically stable when attending the study.

Body mass index (BMI) is 18.5 to 24.9 kg/m2.

History of unilateral exertional leg pain,

Disqualifiers

cardiovascular insufficiency,

Recent myocardial infarction,

heart failure,

arrhythmia,

Trial design

Treatments tested in this trial

  • The BREATHER
  • pharmacological treatment

Treatment groups

60 Participants
are divided into 2 treatment groups

Sponsors and collaborators